Koyfin Home > Directory > Health Care > Antares Pharma > Total Equity

Antares Pharma Total Equity Chart (ATRS)

Antares Pharma annual/quarterly Total Equity from 2000 to 2018.
  • Antares Pharma Total Equity for the quarter ending December 12, 2018 was $39m a 27.57% increase of 11m year over year
  • Antares Pharma Total Equity for the last 12 months ending December 12, 2018 was $39m a 27.57% increase of 11m year over year
  • Antares Pharma Annual Total Equity for 2018 was $39m a 13.98% increase of 5m from 2017
  • Antares Pharma Annual Total Equity for 2017 was $34m a -34.79% decrease of -12m from 2016
  • Antares Pharma Annual Total Equity for 2016 was $45m a -48.27% decrease of -22m from 2015
Other Balance Sheet Metrics:
  • Antares Pharma Total Assets for the quarter ending December 12, 2018 was $88m a 19.07% increase of 17m year over year
  • Antares Pharma Other Liabilities for the quarter ending September 09, 2018 was $0m a 0.00% decrease of 0m year over year
View Chart On Koyfin

Quarterly ATRS Total Equity Data

12/2018$39m
09/2018$24m
06/2018$25m
03/2018$28m
12/2017$34m
09/2017$36m
06/2017$40m
03/2017$41m
12/2016$45m
09/2016$49m

Annual ATRS Total Equity Data

2018$39m
2017$34m
2016$45m
2015$67m
2014$41m
2013$71m
2012$87m
2011$31m
2010$7m
2009$9m